A framework to support new product introduction in national health systems
About the Clinton Health Access Initiative
The Clinton Health Access Initiative (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries. We work with our partners to strengthen the capabilities of governments and the private sector to create and sustain high-quality health systems that can succeed without our assistance.
CHAI was founded in 2002 with a transformational goal: help save the lives of millions of people living with HIV/AIDS. Today, along with HIV, we work with partners to prevent and treat malaria, tuberculosis, hepatitis, and cancer, accelerate the rollout of lifesaving vaccines, reduce maternal, infant and child mortality, combat chronic malnutrition, and strengthen health systems. We operate in over 35 countries around the world and more than 125 countries have access to CHAI-negotiated deals on medications, diagnostics, vaccines, and other health tools.
About the Global HIV Access Program
Since 2002, CHAI has been a leader in expanding and accelerating access to HIV treatment, reducing the cost of drugs and diagnostic tests, and strengthening the capacity of governments to help prevent and diagnose HIV and treat people living with HIV. CHAI’s simultaneous engagement on the supply and demand sides of the market, and our end-to-end, holistic support to national HIV programs is helping to address barriers that prevent people living in LMICs from accessing the best available treatment and prevention services. Recent highlights of our work include negotiating a landmark pricing deal for TLD, an optimal treatment regimen containing dolutegravir, accelerating its introduction across dozens of LMICs, and delivering over US $1.6B in savings.